(Q42503887)

English

Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect

scientific article

Statements

Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect (English)
Junichi Enokizono
Hiroyuki Kusuhara
Yuichi Sugiyama
8 November 2006
209-214

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit